Does bleeding with dabigatran predict occult cancers in patients with nonvalvular atrial fibrillation?
Major bleeding in atrial fibrillation patients taking dabigatran is strongly associated with occult cancers, suggesting bleeding events may serve as a warning sign for underlying malignancy.
AIM: The aim of this study was to examine cancer and bleeding in atrial fibrillation patients administered with dabigatran. MATERIALS p = 0.003) was a significant predictor of major bleeding. CONCLUSION: Bleeding was associated with the presence of cancer.
Koike et al. (Mon,) studied this question.